These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacokinetic and pharmacodynamic evaluations of a potent analgesic, dihydroetorphine, in hairless rat. Ohmori S, Hayashi T, Kawase M, Saito S, Morimoto Y. J Pharmacol Exp Ther; 2001 Feb; 296(2):528-36. PubMed ID: 11160640 [Abstract] [Full Text] [Related]
5. Pharmacological study of dihydroetorphine in cloned mu-, delta- and kappa-opioid receptors. Katsumata S, Minami M, Nakagawa T, Iwamura T, Satoh M. Eur J Pharmacol; 1995 Nov 30; 291(3):367-73. PubMed ID: 8719422 [Abstract] [Full Text] [Related]
6. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells. Crain SM, Shen KF. Brain Res; 1996 Nov 25; 741(1-2):275-83. PubMed ID: 9001733 [Abstract] [Full Text] [Related]
7. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction. Robinson SE. CNS Drug Rev; 2002 Nov 25; 8(4):377-90. PubMed ID: 12481193 [Abstract] [Full Text] [Related]
8. Tolerance to analgesia and dependence liability by topical application of dihydroetorphine to hairless rats. Ohmori S, Fang L, Kawase M, Saito S, Morimoto Y. Eur J Pharmacol; 2001 Jul 06; 423(2-3):157-66. PubMed ID: 11448480 [Abstract] [Full Text] [Related]
9. [Binding of [3H] dihydroetorphine to opioid receptors in rat brain membrane]. Wang DX, Qin BY. Zhongguo Yao Li Xue Bao; 1996 May 06; 17(3):281-3. PubMed ID: 9812759 [Abstract] [Full Text] [Related]
11. TH-030418: a potent long-acting opioid analgesic with low dependence liability. Yu G, Yan LD, Li YL, Wen Q, Dong HJ, Gong ZH. Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug 06; 384(2):125-31. PubMed ID: 21594658 [Abstract] [Full Text] [Related]
12. A potent mu-opioid receptor agonist, dihydroetorphine, fails to produce the conditioned place preference in mice. Tokuyama S, Nakamura F, Nakao K, Takahashi M, Kaneto H. Jpn J Pharmacol; 1996 Aug 06; 71(4):357-60. PubMed ID: 8886936 [Abstract] [Full Text] [Related]
13. Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice. Kamei J, Suzuki T, Nagase H. Neurosci Lett; 1996 Sep 06; 215(2):87-90. PubMed ID: 8888002 [Abstract] [Full Text] [Related]
14. Tramadol and dihydroetorphine produce synergistic analgesic effect and postpones acute opiate tolerance in rats. Ming XY, Wang W, Han JS, Luo F. Sheng Li Xue Bao; 2005 Dec 25; 57(6):696-704. PubMed ID: 16344893 [Abstract] [Full Text] [Related]
15. Antinociceptive effect of dihydroetorphine following various routes of administration: a comparative study with morphine. Tokuyama S, Nakamura F, Takahashi M, Kaneto H. Biol Pharm Bull; 1996 Mar 25; 19(3):477-9. PubMed ID: 8924922 [Abstract] [Full Text] [Related]
16. Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence. Wang YH, Sun JF, Tao YM, Xu XJ, Chi ZQ, Liu JG. Acta Pharmacol Sin; 2010 Apr 25; 31(4):393-8. PubMed ID: 20228826 [Abstract] [Full Text] [Related]
17. [Development of opioid tolerance -- molecular mechanisms and clinical consequences]. Freye E, Latasch L. Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan 25; 38(1):14-26. PubMed ID: 12522725 [Abstract] [Full Text] [Related]
18. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M. Brain Res; 2006 Apr 14; 1083(1):61-9. PubMed ID: 16530171 [Abstract] [Full Text] [Related]
19. Transdermal delivery of the potent analgesic dihydroetorphine: kinetic analysis of skin permeation and analgesic effect in the hairless rat. Ohmori S, Hayashi T, Kawase M, Saito S, Sugibayashi K, Morimoto Y. J Pharm Pharmacol; 2000 Dec 14; 52(12):1437-49. PubMed ID: 11197071 [Abstract] [Full Text] [Related]
20. Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors. McLaughlin JP, Nowak D, Sebastian A, Schultz AG, Archer S, Bidlack JM. Eur J Pharmacol; 1995 Dec 27; 294(1):201-6. PubMed ID: 8788432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]